CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

MGXMetagenomi Therapeutics, Inc.

NASDAQ · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close $1.06 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market cap$40.04M
CountryUSA
RECENT INSIDER TRADES
  • 2026-09-11 · Reid Laurence (Director) · BUY
  • 2026-09-10 · Irish Jian (See Remarks) · SELL
  • 2026-09-10 · Wapnick Pamela (Chief Financial Officer) · SELL
  • 2026-09-10 · Wein Matthew (See Remarks) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders53
Shares held9,011,857
Value$13.44M
Percent of shares outstanding23.86%
As of quarter end2026-06-30
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Metagenomi Therapeutics, Inc. (MGX) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit